review, we highlight past and recent advances in the cell biological regulation of PRR signaling, with a focus on the TLR family. Specifically, we explore the emerging view that microbe-inducible trafficking pathways are important to both promote and inactivate TLR signal transduction, with unique signaling pathways emanating from specific organelles. This idea has placed membrane trafficking pathways at the very center of TLR regulation, with significant importance for advancing our understanding of basic biology and human health.
| GENERAL FEATURES OF THE TLR FAMILY
TLRs are type I transmembrane proteins that are composed of 3 distinct structural elements: a leucine-rich repeat containing ectodomain involved in ligand binding, a transmembrane domain and a cytosolic tail harboring the Toll/IL-1 receptor homology (TIR) domain that binds downstream adaptor proteins. 13 Structural studies revealed that ligandinduced receptor dimerization is a common means of activating TLR signal transduction. A total of 13 mammalian TLRs have been identified and subsets of TLRs are expressed differentially in humans and mice.
Humans express TLRs-1 to -10; whereas mice express TLRs-1 to -9 and
TLRs-11 to -13. TLRs are categorized broadly as either cell surface or endosomal receptors. 1 Specifically, TLRs-1, -2, -4, -5, and -6 localize at the plasma membrane, and recognize surface molecules derived from microorganisms. In contrast, TLRs-3, 7-9, 11-13 localize within the endosomal network where they sense nucleic acid species and components of intracellular parasites 1, 4 (Table 1) . Therefore, the steady-state positions of TLRs correlate with the nature of the ligands they detect, and likely evolved this feature to maximize rapid recognition.
| MICROBE-INDUCIBLE ENDOCYTOSIS PATHWAYS THAT REGULATE TLR SIGNALING
While the primary sites of TLR residence ensure detection of microbial ligands, the site of ligand recognition does not always represent the site of signal transduction. Rather, microbe-induced receptor trafficking is required to promote cellular responses directed by these receptors. In this section, we introduce how microbial ligands induce the movement of TLRs to promote diverse host responses.
Much of our current knowledge of ligand-induced TLR trafficking originated from the characterization of TLR4. As the prototype of the mammalian TLR family, TLR4 senses extracellular lipopolysaccharide (LPS), the major outer membrane component of Gram-negative bacteria. 7, 8, 14 Upon sensing LPS, TLR4 engages 4 TIR domain-containing adaptors (MyD88, TIRAP, TRAM and TRIF) to activate diverse transcription factors that induce proinflammatory cytokine production (via NF-ĸB and AP-1) and type I interferon (IFN) responses (via IFN regulatory factors [IRFs] ). [15] [16] [17] [18] Although TLR4 is required for the induction of transcriptional responses to picomolar concentration of LPS, TLR4 alone is not sufficient to complete the LPS recognition process. Indeed, expression of TLR4 alone did not confer LPS responsiveness to reporter cell lines, 19 and biophysical studies
showed that TLR4 has a relatively low affinity to LPS (K d at the order of 10 5 ) in solution. 20, 21 Indeed, several host accessory proteins operate with TLR4 to facilitate high-affinity detection of LPS in the extracellular milieu. These proteins are LPS-binding protein (LBP), CD14
and MD-2. 19, 22, 23 The detailed mechanism of how these proteins operate coordinately to sense extracellular LPS has been reviewed elsewhere. 24 In brief, the LPS-binding affinity of these proteins increases gradually from LBP, CD14, to the TLR4/MD-2 complex, thereby ensuring the unidirectional delivery of LPS from the extracellular space to TLR4. 25 Recent studies have revealed that, in addition to their LPSbinding/transport activities, CD14 and MD-2 function to transport TLR4 to signaling-competent subcellular locations. An example of this principle came from studies of CD14, a glycosylphosphatidylinositol (GPI)-anchored protein that resides on discrete plasma membrane sub-domains known as the lipid rafts. 23 Owing to the lack of a cytosolic signaling domain, CD14 was once considered to function merely to deliver LPS to TLR4. However, CD14 is now recognized to transport TLR4 to lipid rafts where the receptor engages the adaptor proteins TIRAP and MyD88 to induce rapid NF-kB activation and proinflammatory cytokine production. 26 Whereas the molecular mechanism underlying this process is defined poorly, CD14-dependent synthesis of PI(4,5)P2 via PIP5K
Iα/PIP5K Iγ, and cellular processes regulated by the small GTPase Arf6, promote the recruitment of TLR4 to lipid rafts (or the formation of lipid rafts around TLR4) by altering plasma membrane lipid composition. 27, 28 CD14 also controls the LPS-induced endocytosis of TLR4. First, as will be described in detail later in this review, TLR4 induces replenish surface TLR4 expression after LPS stimulation. 48 The precise molecular mechanism of the cargo-selection for intracellular TLR4 trafficking and the complete repertoire of host factors that regulate these trafficking events represent potentially fruitful directions that warrant further investigation.
The idea that microbial detection can promote receptor trafficking also applies to the operation TLR2. Similar to TLR4, TLR2 engages the adaptor pair MyD88 and TIRAP to propagate signal transduction.
However, a fundamental difference between these 2 TLRs is that TLR4 forms a homodimer via MD-2 to trigger signal transduction, whereas TLR2 forms heterodimers with TLR1 or TLR6 to mediate ligand binding and inflammatory signal transduction. 49 The TLR2 heterodimers employs several accessory molecules, such as CD14, CD36
and Mannose-binding lectin (MBL), to facilitate ligand recognition. [50] [51] [52] In particular, CD14 facilitates ligand recognition by the TLR1/2 heterodimer, 51 whereas CD36 functions as the co-receptor for the TLR2/6 heterodimer. 52 Altogether, the flexibility in receptor pairing and the diversity in accessory protein utilization enable TLR2 to sense a broad spectrum of microbial surface products.
53,54
Akin to the role of CD14 in TLR4 signaling at the plasma membrane, CD36 shuttles the TLR2/6 heterodimer to lipid rafts in a ligand-inducible manner. 55 In addition to its role in mediating uptake (Figure 2) . 20, 63, 64 The molecular mechanisms underlying the operation of these TLR9 accessory molecules have been reviewed elsewhere. 65 In brief, identified by a proteomic screen searching for TLR9-interacting proteins in Raw264.7 cells, granulin is a secreted protein that can be found in the serum at high-concentration. 66 Further analysis reveals that granulin is also able to bind CpG-DNA, thereby forming a granulin-DNA-TLR9 complex that promotes ligand recognition by TLR9. In addition, it serves as a marker for necroptosis and a danger signal for tissue damage. 68 In the context of TLR9 signaling, CpG-DNA stimulation enhances the expression and secretion of HMGB-1, which in turn binds to CpG-DNA and delivers it to TLR9. 63,69 HMGB-1-deficient macrophages and DCs produce less proinflammatory cytokines upon CpG-DNA stimulation in comparison to their WT counterparts. 63, 69 Furthermore, supplementing exogenous HMGB-1 could rescue the defect in cytokine production caused by HMGB-1 deficiency. 63 These discoveries establish the role of HMGB-1 in promoting ligand recognition by TLR9. However, the same study also reported that the cytosolic pool of HMGB-1 associates with TLR9
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prior to CpG-DNA stimulation. 63 As such, further studies are required to elucidate how the extracellular and intracellular pools of HMGB-1 co-ordinate to facilitate TLR9-CpG-DNA interaction. Finally, LL-37 is a well-known broad-spectrum antimicrobial peptide composed of 37 amino acids. 70 Overall, an emerging theme from these studies is that diverse host factors promote ligand sensing by TLR9, but how these proteins function coordinately with each other during TLR9 signaling activation and whether these factors (granulin, HMGB-1, LL37 and CD32) function as TAXI proteins that couple ligand recognition to the intracellular transport of TLR9 await further investigation.
The outcomes of TLR9 signaling display cell-type specificity and are determined by the subcellular compartments where TLR9 activation occurs. For instance, macrophages and conventional DCs (cDCs) produce inflammatory cytokines (TNFα, IL-6 and IL-12p40) upon CpG-DNA stimulation, whereas plasmacytoid DCs (pDCs) produce type I IFN in addition to proinflammatory cytokines. [74] [75] [76] Such differences were originally ascribed to the putative pDC-specific expression pattern of transcription factors, such as a high steady-state level of IRF7 expression. 75, 76 However, cell biological analysis using different types of TLR9 ligands revealed that differential trafficking of TLR9 to specific intracellular compartments determines the observed distinct signaling outcomes in pDCs. Specifically, the aggregationprone form of CpG-DNA (CpG-A) traffics to early endosomes, where TLR9 promotes the IRF7-dependent induction of type I IFN induction. 76 In contrast, the monomeric form of CpG-DNA (CpG-B) traffics to late endosomes/lysosomes (labeled with lysotracker), where TLR9 signaling triggers NF-κB activation to produce inflammatory cytokines. 76 The mechanisms by which distinct forms of CpG-DNA are targeted to different endosomal compartments remain unclear. 80 Iwasaki and colleagues discovered that upon ligand stimulation, AP-3 binds to TLR9 and mediates the movement of this receptor from VAMP3-positive endosomes to LAMP2-positive LROs. 78 Biochemically, AP-3 bridges the interaction between the E3 ubiquitin ligase TRAF3 and the transcription factor IRF7, thereby forming a signaling complex that promotes type I IFN production. 78 In keeping with these findings, AP-3 deficiency abolishes type I IFN FIGURE 2 Ligand-induced trafficking of endosomal Toll-like receptors (TLRs) with a primary focus on TLR9. In macrophages and conventional dendritic cells (DCs), host factors such as LL-37, HMGB-1 and granulin facilitate the delivery of CpG-DNA to TLR9, which then induces myddosome formation at endosomes to induce proinflammatory cytokine production. In plasmacytoid DCs (pDCs), LL-37 and CD32 mediate the delivery of DNA-immune complexes to TLR9. CpG-DNA-induced TLR9 ubiquitinylation and hepatocyte growth factor regulated tyrosine kinase substrate (HRS)-dependent intracellular sorting are required for the activation of TLR9 signaling. In addition, proteolytic processing of TLR9 by endosomal cathepsins and asparagine endopeptidases (AEP) licenses TLR9 signaling. In pDCs, TLR9 trafficking to distinct intracellular compartments induces different signaling outcomes. A study led by Honda et al proposes the model by which the forms of CpG determine the outcome of the transcriptional responses. In particular, the aggregation-prone CpG-A induces type I IFN production from early endosomes, whereas the monomeric CpG-B induces proinflammatory cytokines from late endosomes/lysosomes. In contrast, studies by Sasai et al and Blasius et al propose the model by which TLR9 induces inflammatory cytokine production in endosomes, and that AP-3-mediated TLR9 trafficking to lysosome-related organelles (LROs) induces type I IFN production. Lastly, in response to the DNA-immune complex, the ligand uptake process is mediated by LAP and the subsequently assembled LAPosome delivers DNA-immune complex to phagosomes where TLR9-dependent signaling occurs to induce type I IFN production. Thus, 3 intracellular compartments in the pDCs have been linked to type I IFN production: the early endosome, the LRO and the phagosome.
production from CpG-DNA stimulated pDCs, further substantiating the tight coupling of receptor compartmentalization to the initiation of specific signaling outcomes (Figure 2) . 78, 79 Of note, whereas AP-3 is absolutely required for type I IFN signaling from pDCs, its role in mediating inflammatory cytokine production in the same cell type is proteins in the cytosol. 81 The molecular mechanism of autophagosome assembly is currently a subject of intense study. This process is orchestrated by a cascade of reactions, including the activation of protein kinases (eg, Ulk1 and Ulk2) and the subsequent protein conjugation processes mediated by various autophagy proteins (ATGs).
81,83
Whereas non-canonical autophagy utilizes the same ATG protein conjugation system as its canonical counterpart, non-canonical autophagy proceeds normally in the absence of Ulk1/2 activation. 84 Furthermore, induction of non-canonical autophagy leads to the formation of a single membrane LC-3 positive structure distinct from the double membrane structure of the canonical autophagosome. 85 In response to DNA-immune complexes, non-canonical autophagy is initiated with the aid of phosphatidylinositol 3-kinase (PI3K) and subsequently facilitates the delivery of DNA-immune complexes and TLR9 to phagosomes, thereby leading to type I IFN production.
82
This non-canonical autophagy-mediated type I IFN response is independent of AP-3 function, as AP-3-deficient pDCs are still able to produce type I IFN in response to DNA immune complexes. 82 Biochemical characterization of the LAP complex revealed that additional components, including Rubicon, UVRAG, Beclin-1 and VPS34, associate with PI3K to initiate LAP formation. 82, 86 Moreover, mice carrying mutations in several LAP components develop autoimmune diseaselike phenotypes resembling systemic lupus erythematosus (SLE). 87 Further studies are warranted to determine the molecular crosstalk between LAP and CD32-mediated TLR9 signaling activation in the context of DNA immune complex stimulation. These findings demonstrate that multiple host trafficking pathways shuttle TLR9 to distinct intracellular compartments to trigger signaling events in response to ligands that exist in divergent forms.
Operating in concert with the aforementioned host factors, the enzymes controlling phosphoinositide (PI) metabolism exert a fundamental layer of control over the intracellular trafficking and signaling outcomes of endosomal TLRs. In general, as distinct panels of PI kinases and phosphatases reside on different organelles, the PIs generated by these enzymes function as "barcodes" that endow these organelles with unique membrane properties. 88 Consistently, perturbing PI metabolism alters the trafficking and signaling outcomes of endosomal TLRs. For instance, chemical inhibition of the PI3K p110δ catalytic subunit, which is preferentially expressed in pDCs and is responsible for PI(3,4,5)P3 generation, abolishes TLR9-induced IFN responses without affecting TNFa and IL-6 production. 89 Further cell biological analysis revealed that p110δ inhibition blocks IRF7 nuclear translocation, thereby disrupting IFN responses. Although the precise biochemical processes and the trafficking events contributing to the abnormal IRF7 nuclear translocation remain elusive, these findings demonstrated the crucial roles of PI3K and PI(3,4,5)P3 in TLR9 signaling. 89 Similarly, another host PI kinase, PIKfyve, which catalyzes the production of PI(3,5)P2, crucially determines signaling outcomes upon TLR9 activation in a cell type-specific manner. 90 Using RAW264. An example of this principle can be found from the studies of TIRAP, whose N-terminal domain exhibits affinity for a broad spectrum of PI species, such as PI(4,5)P2 and PI(3)P. 77, 98 The PI(4,5)P2 binding property of TIRAP allows it to localize to subdomains of the plasma membrane that are rich in membrane ruffles. 98 These structures are likely to be the operational equivalent of lipid rafts, although direct assessment of the localization of TIRAP to rafts has not been performed.
Current views suggest that upon LPS encounter, TIRAP senses a dimerized TLR4 complex upon its delivery to lipid rafts by CD14. 26, 98 Subsequently, TIRAP bridges ligand-bound TLR4 to MyD88 which seeds the formation of the myddosome, a supramolecular organizing center (SMOC) composed of TIRAP, MyD88 and IRAK family kinases. 99, 100 The formation of the myddosome triggers a cascade of downstream signaling events, which culminates in the activation of NF-κB and the production of inflammatory cytokines. 101, 102 The idea of the myddosome was based originally on in vitro analysis of the MyD88-IRAK kinases complex, 103 but whether this complex exists in living cells and whether it is stably present or ligand-inducible has been unclear. Studies of TIRAP revealed this adaptor as a regulator of myddosome assembly, and revealed that this SMOC is assembled inducibly upon microbial detection. 77, 100 Of note, several posttranslational modifications (ie, phosphorylation, proteolytic cleavage, and ubiquitinylation) target distinct regions of TIRAP, indicating that the activity of TIRAP, as well as the assembly of myddosome, may be subject to multiple layers of regulation. [104] [105] [106] Owing to the promiscuous nature of its PI-binding motif, TIRAP can also be found on endosomes via interactions with PI(3)P. 77 115 Others have shown that upon infection by
Borrelia burgdorferi, the causative agent of Lyme disease, TRIF facilitates the production of IL-6 and type I IFN from intracellular compartments, and the aforementioned adaptor protein AP-3 is required for this intracellular signaling process. 113, 116 However, work on the roles of TRAM and TRIF in TLR2 signaling must continue, as the mechanisms-underlying the actions of these adaptors pairs are largely unexplored.
| CONCLUSION AND FUTURE PERSPECTIVES
In this review, we have highlighted past and recent discoveries on regulatory mechanisms that govern the trafficking of TLRs. In particular, there is a growing appreciation that microbe-induced receptor trafficking aided by TAXI proteins (Table 2 ) represents a regulatory means to control TLR signaling. Despite these advances, our knowledge of the cell biology of TLR trafficking, especially at the receptor proximal level, remains rudimentary. Indeed, whereas cell biological analysis of TLR signaling has yielded fruitful discoveries that connect distinct components within the pathway, additional questions persist.
We consider the question of how diverse TLR accessory proteins co-ordinate ligand recognition and trafficking of their cognate TLRs as a fertile territory for future research. In addition, because the heterogeneity of endosomes dictates the signaling outcomes of TLRs that reside in them, the precise nature of these distinct intracellular signaling compartments awaits further elucidation. Lastly, cell typespecific regulation of TLR trafficking represents an attractive area for future studies. In conclusion, the knowledge obtained from cell biological characterization of the TLR pathway has been and will likely continue to advance our understanding of general cell biology of the host.
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